Concepedia

Youssef M.K. Farag

YM

Statistics

Publications

8

Citations

638

H-Index

8

Active since

2019

Affiliations

Akebia Therapeutics (United States)(Current)

Johns Hopkins University

Indiana University – Purdue University Indianapolis

Charité - Universitätsmedizin Berlin

Vanderbilt University Medical Center

Youssef M.K. Farag is an author at Akebia Therapeutics (United States) specializing in chronic kidney disease, journalism, and dialysis.

ORCID

Top concepts

Publications per year

2019–2023

8

Publications

8

Vadadustat in Patients with Anemia and Non–Dialysis-Dependent CKD

Glenn M. Chertow, Pablo E. Pérgola, Youssef M.K. Farag et al. · New England Journal of Medicine · 2021 · 231 citations · Full text

Safety and Efficacy of Vadadustat for Anemia in Patients Undergoing Dialysis

Kai‐Uwe Eckardt, Rajiv Agarwal, Ahmad Aswad et al. · New England Journal of Medicine · 2021 · 185 citations · Full text

Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes

Rajiv Agarwal, Wanzhu Tu, Alfredo E. Farjat et al. · Annals of Internal Medicine · 2023 · 73 citations

Vadadustat, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor, for treatment of anemia of chronic kidney disease: two randomized Phase 2 trials in Japanese patients

Masaomi Nangaku, Youssef M.K. Farag, Emil M. deGoma et al. · Nephrology Dialysis Transplantation · 2020 · 39 citations

Global Dialysis Perspective: Egypt

Youssef M.K. Farag, Enass Elsayed · Kidney360 · 2022 · 37 citations · Full text

, , +14

1–5 of 8